HOME >> BIOLOGY >> NEWS
X marks the spot: Vector insertion is viral specific

(Philadelphia, PA) - Retroviruses are one of the most common vehicles for delivering therapeutic payloads via gene therapy in animal models of disease and human patients. Viruses integrate into host DNA to replicate, but exactly where they insert themselves has become a topic of increasing importance. This is of special concern when integration is near an oncogene that may lead to uncontrolled, cancerous cell growth.

Now, researchers at the University of Pennsylvania School of Medicine have completed the first whole-genome survey of where three commonly used retroviruses integrate into human DNA. The team, led by Frederic Bushman, PhD, Professor of Microbiology, compared vectors derived from human immunodeficiency virus (HIV), murine leukemia virus (MLV), and avian sarcoma-leukosis virus (ASLV). They found that HIV integrated near active genes; MLV near points on the chromosome where protein translation starts (which confirms earlier work by another lab); and ASLV integrated more randomly throughout the entire genome. That each studied virus preferred a unique integration pattern or site suggests that viruses home in on certain chromosomal features for inserting themselves within the genome. This work appears in the August 17 issue of PLoS Biology, a new open-access journal.

"There's a picture forming of where different retroviruses integrate in human cells, and it seems to be quite different from virus to virus, which is not something anyone would have ever suspected," says Bushman. "We can only speculate as to the mechanism at present, but one attractive idea is that retroviral-integration complexes bind to cellular DNA binding proteins attached to specific locations on chromosomes." For HIV, integrating into active genes may help promote efficient viral gene expression. The reason for the choice of target is less clear in other retroviruses.

These findings are important for devising safer human gene-therapy veh
'"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
16-Aug-2004


Page: 1 2

Related biology news :

1. Rensselaer marks the opening of the center for biotechnology and interdisciplinary studies
2. Despite darkness, nocturnal bees learn visual landmarks while foraging at night
3. High Flux Isotope Reactor marks 400th cycle
4. Study marks increased trends in infectious disease occurrences in our oceans
5. Making of mouse marks move toward mitochondrial medicine
6. Over land, sea and air, users give MERIS high marks
7. An eye for scent marks
8. Allergen-free shrimp? seafood marks a place in food safety research
9. Structure solved by scientists at The Scripps Research Institute marks important milestone in effort to develop HIV vaccine
10. Tenth edition of Hopkins guide to AIDS care marks historic milestone in battle against AIDS
11. New mouse marks latest stride in muscular dystrophy research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/19/2019)... ... , ... Nativis, Inc., today announced the Company has changed ... immediately for the clinical stage, therapeutic device company, which is developing non-invasive treatments ... Rivera, Chief Executive Officer, said, “the renaming of the company to EMulate Therapeutics, ...
(Date:3/18/2019)... ... March 18, 2019 , ... uBiome, the ... and the third highest quality portfolio following Seres Health and Nestle, as published ... Moser, and Theodor Myfleler. uBiome executives Dr. Jessica Richman, PhD, co-founder and CEO, ...
(Date:3/18/2019)... ... , ... Early engagement not only improves and makes research ... by better balancing scientific objectives with patient goals. , Reaching out to patient ... from development to market. Involving these groups in this manner ensures better information ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... Israel and BASEL, Switzerland (PRWEB) , ... ... ... Sheba Medical Center at Tel HaShomer, the largest hospital in Israel and ... develop point-of-care cell-therapy manufacturing using the state-of-the-art Cocoon™ manufacturing platform. The partnership ...
(Date:3/15/2019)... ... March 15, 2019 , ... ... and affiliate companies including AVAPCO LLC and API Intellectual Properties Holdings. The ... and R&D center in Thomaston, Georgia, operations, research, and business development staff ...
(Date:3/14/2019)... ROCK, Ark. (PRWEB) , ... March 14, 2019 ... ... America’s 29th Annual Conference & Expo, themed “Navigating the Full Spectrum of Case ... Vegas, NV, June 10-14, 2019. This conference is the only case management industry ...
(Date:3/14/2019)... ... March 13, 2019 , ... The International Society for ... taking place in Brussels, Belgium on 25–26 September 2019. This event is a ... innovative approaches. , “Biopharmaceuticals have become a main pillar in the pharmaceutical ...
Breaking Biology Technology:
Cached News: